Literature DB >> 26261320

Biologically active LIL proteins built with minimal chemical diversity.

Erin N Heim1, Jez L Marston1, Ross S Federman2, Anne P B Edwards1, Alexander G Karabadzhak3, Lisa M Petti1, Donald M Engelman4, Daniel DiMaio5.   

Abstract

We have constructed 26-amino acid transmembrane proteins that specifically transform cells but consist of only two different amino acids. Most proteins are long polymers of amino acids with 20 or more chemically distinct side-chains. The artificial transmembrane proteins reported here are the simplest known proteins with specific biological activity, consisting solely of an initiating methionine followed by specific sequences of leucines and isoleucines, two hydrophobic amino acids that differ only by the position of a methyl group. We designate these proteins containing leucine (L) and isoleucine (I) as LIL proteins. These proteins functionally interact with the transmembrane domain of the platelet-derived growth factor β-receptor and specifically activate the receptor to transform cells. Complete mutagenesis of these proteins identified individual amino acids required for activity, and a protein consisting solely of leucines, except for a single isoleucine at a particular position, transformed cells. These surprisingly simple proteins define the minimal chemical diversity sufficient to construct proteins with specific biological activity and change our view of what can constitute an active protein in a cellular context.

Entities:  

Keywords:  E5 protein; PDGF receptor; oncogene; synthetic biology; traptamer

Mesh:

Substances:

Year:  2015        PMID: 26261320      PMCID: PMC4553812          DOI: 10.1073/pnas.1514230112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

Review 1.  Structural biology of the T-cell receptor: insights into receptor assembly, ligand recognition, and initiation of signaling.

Authors:  Kai W Wucherpfennig; Etienne Gagnon; Melissa J Call; Eric S Huseby; Matthew E Call
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03-17       Impact factor: 10.005

2.  Artificial transmembrane oncoproteins smaller than the bovine papillomavirus E5 protein redefine sequence requirements for activation of the platelet-derived growth factor beta receptor.

Authors:  Kristina Talbert-Slagle; Sara Marlatt; Francisco N Barrera; Ekta Khurana; Joanne Oates; Mark Gerstein; Donald M Engelman; Ann M Dixon; Daniel Dimaio
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

3.  De novo design of transmembrane helix-helix interactions and measurement of stability in a biological membrane.

Authors:  Anthony Nash; Rebecca Notman; Ann M Dixon
Journal:  Biochim Biophys Acta       Date:  2015-02-27

4.  Construction and genetic selection of small transmembrane proteins that activate the human erythropoietin receptor.

Authors:  Tobin J Cammett; Susan J Jun; Emily B Cohen; Francisco N Barrera; Donald M Engelman; Daniel Dimaio
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-08       Impact factor: 11.205

5.  Extension of the CHARMM General Force Field to sulfonyl-containing compounds and its utility in biomolecular simulations.

Authors:  Wenbo Yu; Xibing He; Kenno Vanommeslaeghe; Alexander D MacKerell
Journal:  J Comput Chem       Date:  2012-07-23       Impact factor: 3.376

Review 6.  The bovine papillomavirus E5 protein and the PDGF beta receptor: it takes two to tango.

Authors:  Kristina Talbert-Slagle; Daniel DiMaio
Journal:  Virology       Date:  2008-11-06       Impact factor: 3.616

Review 7.  Protein-protein interactions in the membrane: sequence, structural, and biological motifs.

Authors:  David T Moore; Bryan W Berger; William F DeGrado
Journal:  Structure       Date:  2008-07       Impact factor: 5.006

8.  Synthetic amphiphilic peptide models for protein ion channels.

Authors:  J D Lear; Z R Wasserman; W F DeGrado
Journal:  Science       Date:  1988-05-27       Impact factor: 47.728

9.  CHARMM-GUI Membrane Builder for mixed bilayers and its application to yeast membranes.

Authors:  Sunhwan Jo; Joseph B Lim; Jeffery B Klauda; Wonpil Im
Journal:  Biophys J       Date:  2009-07-08       Impact factor: 4.033

Review 10.  Association energetics of membrane spanning alpha-helices.

Authors:  Kevin R MacKenzie; Karen G Fleming
Journal:  Curr Opin Struct Biol       Date:  2008-06-05       Impact factor: 6.809

View more
  22 in total

1.  De novo designed transmembrane peptides activating the α5β1 integrin.

Authors:  Marco Mravic; Hailin Hu; Zhenwei Lu; Joel S Bennett; Charles R Sanders; A Wayne Orr; William F DeGrado
Journal:  Protein Eng Des Sel       Date:  2018-05-01       Impact factor: 1.650

2.  Comparing side chain packing in soluble proteins, protein-protein interfaces, and transmembrane proteins.

Authors:  J C Gaines; S Acebes; A Virrueta; M Butler; L Regan; C S O'Hern
Journal:  Proteins       Date:  2018-02-26

Review 3.  Membrane receptor activation mechanisms and transmembrane peptide tools to elucidate them.

Authors:  Justin M Westerfield; Francisco N Barrera
Journal:  J Biol Chem       Date:  2019-12-25       Impact factor: 5.157

4.  Biologically Active Ultra-Simple Proteins Reveal Principles of Transmembrane Domain Interactions.

Authors:  Ross S Federman; Anna-Sophia Boguraev; Erin N Heim; Daniel DiMaio
Journal:  J Mol Biol       Date:  2019-07-10       Impact factor: 5.469

Review 5.  Small size, big impact: how studies of small DNA tumour viruses revolutionized biology.

Authors:  Daniel DiMaio
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-27       Impact factor: 6.237

Review 6.  How physical forces drive the process of helical membrane protein folding.

Authors:  Karolina Corin; James U Bowie
Journal:  EMBO Rep       Date:  2022-02-08       Impact factor: 8.807

Review 7.  Protein Design: From the Aspect of Water Solubility and Stability.

Authors:  Rui Qing; Shilei Hao; Eva Smorodina; David Jin; Arthur Zalevsky; Shuguang Zhang
Journal:  Chem Rev       Date:  2022-08-03       Impact factor: 72.087

8.  IL23R (Interleukin 23 Receptor) Variants Protective against Inflammatory Bowel Diseases (IBD) Display Loss of Function due to Impaired Protein Stability and Intracellular Trafficking.

Authors:  Durga Sivanesan; Claudine Beauchamp; Christiane Quinou; Jonathan Lee; Sylvie Lesage; Sylvain Chemtob; John D Rioux; Stephen W Michnick
Journal:  J Biol Chem       Date:  2016-02-17       Impact factor: 5.157

Review 9.  Traptamer screening: a new functional genomics approach to study virus entry and other cellular processes.

Authors:  Jian Xie; Daniel DiMaio
Journal:  FEBS J       Date:  2021-05-08       Impact factor: 5.542

10.  Disrupting the transmembrane domain-mediated oligomerization of protein tyrosine phosphatase receptor J inhibits EGFR-driven cancer cell phenotypes.

Authors:  Elizabeth Bloch; Eden L Sikorski; David Pontoriero; Evan K Day; Bryan W Berger; Matthew J Lazzara; Damien Thévenin
Journal:  J Biol Chem       Date:  2019-11-01       Impact factor: 5.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.